-+ 0.00%
-+ 0.00%
-+ 0.00%
Inovio Pharmaceuticals Appoints Jeffrey Libson to Board
Share
Listen to the news
Inovio Pharmaceuticals Appoints Jeffrey Libson to Board
  • Inovio Pharmaceuticals appointed Jeffrey Libson to its board, effective November 13, 2026.
  • The board expanded from eight to nine directors; Libson also joined its Finance Committee effective the same date.
  • Libson was a Cooley partner from December 2016 to January 2025, advising life sciences companies, boards, entrepreneurs and investors.
  • His board term runs through the 2027 annual stockholders meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-465502), on November 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending